United States Antimony Corporation is undergoing a capital-intensive expansion, with PPE growing from $7.7M in 2024Q1 to $53.5M in 2026Q2, but this has not translated into profitability.
Price trend, volume and key moving averages
Trailing total returns as of 11/8/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC).
Check whether operating performance supports the current valuation.
Recent results and news deserve attention only when they alter the forward view.
| Quarter | EPS (Act vs Est) | Revenue (Act vs Est) |
|---|---|---|
Q3 2026Latest Aug 11, 2026 | $0.00-73.6% vs $0.00 | $8M-63.5% vs $22M |
Q2 2026 May 14, 2026 | -$0.08-300.0% vs -$0.02 | $7M-54.2% vs $15M |
Q2 2026 Mar 19, 2026 | -$0.01+0.0% vs -$0.01 | $13M+2.1% vs $13M |
Q4 2025 Nov 12, 2025 | -$0.04-300.0% vs $0.02 | $9M-40.6% vs $15M |
Critical Metals is sliding as newly issued shares from its European Lithium acquisition prepare to hit Nasdaq, and the question now is whether incoming sellers and a looming Fed decision pile on before the company has earned a single dollar
Buying in critical minerals stocks is spreading across the group, lifting an antimony producer, a domestic rare earth magnet builder and a Greenland-focused developer together. United States Antimony (NYSE:UAMY) stock is at $3.
European Lithium holders voted heavily for a takeover that would give their acquirer full control of a Greenland rare earth project, and shares of the buyer are sliding anyway. Critical Metals (NASDAQ:CRML) stock is at $6.
United States Antimony NYSE: UAMY is expanding its processing capacity, pursuing domestic mineral supply sources and advancing a proposed antimony, copper and silver processing joint venture as it seeks to serve U.S. defense and industrial customers, Vice President of Investor Relations and Global Sales Director Jonathan Miller said during a company presentation.
Benchmark UAMY against direct peers instead of judging its metrics in isolation.
Key metrics vs top competitors for United States Antimony Corporation (UAMY)
| Company | Price | Market Cap | P/E Ratio | Rev Growth (1Y) | Net Margin | ROE | Div Yield |
|---|---|---|---|---|---|---|---|
| $2.82 | $417.88M | -26.33 | 162.81% | -44.6% | -12.37% | — | |
| $3.09 | $1.04B | -21.08 | 17.71% | -26.39% | -23.94% | — | |
| $7.84 | $2.32B | 40.02 | 115.25% | 8.73% | 10.49% | — | |
| $14.74 | $9.89B | 26.07 | 53.03% | 24.1% | 14.36% | 0.1% | |
| $15.47 | $15.94B | 22.96 | 96.41% | 19.25% | 8.02% | — | |
| $35.41 | $6.3B | -159.79 | 10.1% | -9.9% | -1.74% | — |
United States Antimony Corporation (UAMY) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
Verify the primary filings, follow material updates, and answer the remaining questions.
United States Antimony Corporation (UAMY) SEC filings — annual & quarterly reports (10-K, 10-Q)
Aug 17, 2026·SEC
Aug 11, 2026·SEC
Aug 6, 2026·SEC
Mar 19, 2026·SEC
Get notified when UAMY posts new earnings or crosses analyst targets
Free. No account needed. Unsubscribe any time.
United States Antimony Corporation (UAMY) stock FAQ — growth, dividends, profitability & financials explained
United States Antimony Corporation (UAMY) reported $36.4M in revenue over the trailing twelve months. Revenue was $39.3M in fiscal year 2025. That is 683% more than the $5.0M of fiscal year 1996.
United States Antimony Corporation (UAMY) grew revenue by 35.1% over the trailing twelve months, compared with the twelve months before.
No. United States Antimony Corporation (UAMY) reported a net loss of $16.3M over the trailing twelve months.
United States Antimony Corporation (UAMY) had a return on equity (ROE) of -12.4% over the trailing twelve months. A negative ROE means the company lost money over the period.
United States Antimony Corporation (UAMY) had negative free cash flow of $71.3M over the trailing twelve months.
